Users Online : 107 About us |  Subscribe |  e-Alerts  | Feedback | Login   |   
Journal of Minimal Access Surgery Current Issue | Archives | Ahead Of Print Journal of Minimal Access Surgery
           Print this page Email this page   Small font sizeDefault font sizeIncrease font size 
 ¤   Next article
 ¤   Previous article
 ¤   Table of Contents

 ¤   Similar in PUBMED
 ¤  Search Pubmed for
 ¤  Search in Google Scholar for
 ¤Related articles
 ¤   Citation Manager
 ¤   Access Statistics
 ¤   Reader Comments
 ¤   Email Alert *
 ¤   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded84    
    Comments [Add]    

Recommend this journal


Year : 2021  |  Volume : 17  |  Issue : 4  |  Page : 542-547

Impact of COVID-19 pandemic on bariatric surgery in India: An obesity and metabolic surgery society of India survey of 1307 patients

1 Saifee Hospital, Mumbai, Maharashtra, India
2 K D Hospital, Ahmedabad, Gujarat, India
3 Sir Ganga Ram Hospital, New Delhi, India
4 All India Institute of Medical Sciences, New Delhi, India
5 LIMA Lifeline Hospital, Chennai, Tamil Nadu, India
6 Artemis Hospital, Gurgaon, Haryana, India
7 Apollo Hospital, New Delhi, India
8 Parul Institute of Medical Science and Research, Vadodara, Gujarat, India
9 BLK Super Speciality Hospital, New Delhi, India
10 Vivek Hospital, Hyderabad, Telangana, India
11 Hope Obesity Centre, Ahmedabad, Gujarat, India
12 Jammu Hospital, Jalandhar, Punjab, India
13 Apollo Clinic, Chennai, Tamil Nadu, India
14 Kular College and Hospitals Private Limited, Ludhiana, Punjab, India
15 Asian Bariatric, Ahmedabad, Gujarat, India
16 Aster CMI Hospital, Bengaluru, Karnataka, India
17 Aastha Healthcare, Mumbai, Maharashtra, India
18 Lilavati Hospital, Mumbai, Maharashtra, India
19 Moulana Hospital, Perintalmanna, Kerala, India
20 LivLife Hospital, Hyderabad, Telangana, India
21 Child Heart International, Chennai, Tamil Nadu, India
22 ILS Hospitals, Kolkata, West Bengal, India
23 Zydus Hospital and Healthcare Research Center, Anand, Gujarat, India
24 Lakeshore Hospital, Kochi, Kerala, India
25 Ajanta Hospital, Lucknow, Uttar Pradesh, India
26 Institute of Bariatrics, Apollo Hospitals, Chennai, Tamil Nadu, India
27 Shree Hospital, Valsad, Gujarat, India
28 Surat Bariatrics, Surat, Gujarat, India
29 Wockhardt Hospital, Mumbai, Maharashtra, India
30 Fortis Hospital, New Delhi, India
31 Vardhman Mahavir Healthcare, Patiala, Punjab, India
32 Belle Vue Clinic, Kolkata, West Bengal, India
33 Laparo-Obeso Centre, Pune; Lilavati Hospital Mumbai and Hinduja Healthcare Surgical, Mumbai, Maharashtra, India
34 Shree Hospital and Diagnostic Centre Private Limited, Pune, Maharashtra, India
35 Apollo Spectra Hospital, New Delhi, India
36 Kirloskar and Virinchi Hospitals, Hyderabad, Telangana, India
37 Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu, India
38 Max Superspecialty Hospital, New Delhi, India

Correspondence Address:
Aparna Govil Bhasker
A 807, Adani Western Heights, JP Road, Opp Gurudawara, Manish Nagar, Andheri West, Mumbai - 400 058, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jmas.JMAS_2_21

Rights and Permissions

Background: Although safe practice guidelines were issued by the Obesity and Metabolic Surgery Society of India (OSSI) in the end of May 2020, surgeons have been in a dilemma about risk of subjecting patients to hospitalisation and bariatric surgery. This survey was conducted with the objective to evaluate the risk of coronavirus disease-19 (COVID-19) infection in peri- and post-operative period after bariatric and metabolic surgery (BMS). Methods: A survey with OSSI members was conducted from 20 July 2020 to 31 August 2020 in accordance with EQUATOR guidelines. Google Form was circulated to all surgeon members through E-mail and WhatsAppTM. In the second phase, clinical details were captured from surgeons who reported positive cases. Results: One thousand three hundred and seven BMS were reported from 1 January 2020 to 15 July 2020. Seventy-eight per cent were performed prior to 31 March 2020 and 276 were performed after 1 April 2020. Of these, 13 (0.99%) patients were reported positive for COVID-19 in the post-operative period. All suffered from a mild disease and there was no mortality. Eighty-seven positive cases were reported from patients who underwent BMS prior to 31 December 2019. Of these, 82.7% of patients had mild disease, 13.7% of patients had moderate symptoms and four patients succumbed to COVID-19. Conclusion: BMS may be considered as a safe treatment option for patients suffering from clinically severe obesity during the COVID-19 pandemic. Due care must be taken to protect patients and healthcare workers and all procedures must be conducted in line with the safe practice guidelines.


Print this article     Email this article

© 2004 Journal of Minimal Access Surgery
Published by Wolters Kluwer - Medknow
Online since 15th August '04